ProjektA prospective, open-label, multicenter, randomized phase III trial to compare the efficacy and safety of a…

Grunddaten

Titel:

A prospective, open-label, multicenter, randomized phase III trial to compare the efficacy and safety of a combined regimen of obinutuzumab and GDC-0199 (ABT-199) versus obinutuzumab and chlorambucil in previously untreated patients with CLL and coexisting medical conditions

Laufzeit:

01.07.2015 bis 30.06.2018

Abstract / Kurz- beschreibung:

A PROSPECTIVE, OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE III TRIAL TO COMPARE THE EFFICACY AND SAFETY OF A COMBINED REGIMEN OF OBINUTUZUMAB AND GDC-0199 (ABT-199) VERSUS OBINUTUZUMAB AND CHLORAMBUCIL IN PREVIOUSLY UNTREATED PATIENTS WITH CLL AND COEXISTING MEDICAL CONDITIONS

Schlüsselwörter:

klinische Studie

clinical trial

Beteiligte Mitarbeiter/innen

Leiter/innen

Nikolaou, Konstantin

Medizinische Fakultät
Universität Tübingen

Lokale Einrichtungen

Abteilung Diagnostische und Interventionelle Radiologie

Radiologische Universitätsklinik (Department)
Kliniken und klinische Institute, Medizinische Fakultät

Geldgeber

Roche Pharma AG

Grenzach-Wyhlen, Baden-Württemberg, Deutschland